Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRADA: Trabectedin vs Adriamycin + Dacarbazine in Solitary Fibrous Tumor
NCT03023124Phase 2Completed
- Sponsor
- Italian Sarcoma Group
- Start
- Mar 2018
- Primary completion
- Dec 2024
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in solitary fibrous tumor (SFT), sponsored by Italian Sarcoma Group. Started Mar 2018; status: completed.
02
Drugs
trabectedin
03
Conditions
solitary fibrous tumor (SFT)
Beyond the preview
Go deeper on NCT03023124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03023124.